Cargando…
Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972042/ https://www.ncbi.nlm.nih.gov/pubmed/36259156 http://dx.doi.org/10.1002/cam4.5246 |
_version_ | 1784898235940208640 |
---|---|
author | Wu, Qiulei Li, Guoqing Gong, Lanqing Cai, Jing Chen, Le Xu, Xiaohan Liu, Xiaoli Zhao, Jing Zeng, Ya Gao, Rui Yu, Lili Wang, Zehua |
author_facet | Wu, Qiulei Li, Guoqing Gong, Lanqing Cai, Jing Chen, Le Xu, Xiaohan Liu, Xiaoli Zhao, Jing Zeng, Ya Gao, Rui Yu, Lili Wang, Zehua |
author_sort | Wu, Qiulei |
collection | PubMed |
description | BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)A regulators was implemented using The Cancer Genome Atlas database (TCGA). To determine the level of m(6)A, RNA m(6)A quantitative assays were used. Then, colony formation assays, EdU assays, wound healing assays, and Transwell assays were performed. The dual‐luciferase reporter assay was used to confirm the miRNA target genes. Protein–protein interaction (PPI) analysis of the target genes was performed, and hub genes were discovered using the cytoHubba/Cytoscape software. The underlying molecular mechanisms were explored by bioinformatics and RNA stability assays. RESULTS: A total of 126 miRNAs were identified as m(6)A‐related miRNAs by Pearson's correlation analysis. Among them, the high level of miR‐30c‐5p was associated with good prognosis in OvCa patients. In vitro, the miR‐30c‐5p agomir lowered the m(6)A level and inhibited OvCa cell proliferation, migration, and invasion. The hub target genes of miR‐30c‐5p were identified as (i) XPO1, (ii) AGO1, (iii) HNRNPA2B1, of which m(6)A reader HNRNPA2B1 was highly expressed in OvCa tissues and related with poor prognosis. In vitro, knockdown of HNRNPA2B1 significantly reduced m(6)A level and hampered the proliferation and migration of OvCa cells. The inhibition of m(6)A reader HNRNPA2B1 attenuated the suppression of proliferation and migration and the low m(6)A level induced by the miR‐30c‐5p downregulation. Mechanistically, m(6)A reader HNRNPA2B1 might regulate CDK19 mRNA stability to alter m(6)A level. CONCLUSIONS: miR‐30c‐5p inhibits OvCa progression and reduces the m(6)A level by inhibiting m(6)A reader HNRNPA2B1, thus providing new insights into the m(6)A regulatory mechanism in OvCa. |
format | Online Article Text |
id | pubmed-9972042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99720422023-03-01 Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer Wu, Qiulei Li, Guoqing Gong, Lanqing Cai, Jing Chen, Le Xu, Xiaohan Liu, Xiaoli Zhao, Jing Zeng, Ya Gao, Rui Yu, Lili Wang, Zehua Cancer Med Research Articles BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)A regulators was implemented using The Cancer Genome Atlas database (TCGA). To determine the level of m(6)A, RNA m(6)A quantitative assays were used. Then, colony formation assays, EdU assays, wound healing assays, and Transwell assays were performed. The dual‐luciferase reporter assay was used to confirm the miRNA target genes. Protein–protein interaction (PPI) analysis of the target genes was performed, and hub genes were discovered using the cytoHubba/Cytoscape software. The underlying molecular mechanisms were explored by bioinformatics and RNA stability assays. RESULTS: A total of 126 miRNAs were identified as m(6)A‐related miRNAs by Pearson's correlation analysis. Among them, the high level of miR‐30c‐5p was associated with good prognosis in OvCa patients. In vitro, the miR‐30c‐5p agomir lowered the m(6)A level and inhibited OvCa cell proliferation, migration, and invasion. The hub target genes of miR‐30c‐5p were identified as (i) XPO1, (ii) AGO1, (iii) HNRNPA2B1, of which m(6)A reader HNRNPA2B1 was highly expressed in OvCa tissues and related with poor prognosis. In vitro, knockdown of HNRNPA2B1 significantly reduced m(6)A level and hampered the proliferation and migration of OvCa cells. The inhibition of m(6)A reader HNRNPA2B1 attenuated the suppression of proliferation and migration and the low m(6)A level induced by the miR‐30c‐5p downregulation. Mechanistically, m(6)A reader HNRNPA2B1 might regulate CDK19 mRNA stability to alter m(6)A level. CONCLUSIONS: miR‐30c‐5p inhibits OvCa progression and reduces the m(6)A level by inhibiting m(6)A reader HNRNPA2B1, thus providing new insights into the m(6)A regulatory mechanism in OvCa. John Wiley and Sons Inc. 2022-10-18 /pmc/articles/PMC9972042/ /pubmed/36259156 http://dx.doi.org/10.1002/cam4.5246 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Wu, Qiulei Li, Guoqing Gong, Lanqing Cai, Jing Chen, Le Xu, Xiaohan Liu, Xiaoli Zhao, Jing Zeng, Ya Gao, Rui Yu, Lili Wang, Zehua Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title | Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title_full | Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title_fullStr | Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title_full_unstemmed | Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title_short | Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer |
title_sort | identification of mir‐30c‐5p as a tumor suppressor by targeting the m(6)a reader hnrnpa2b1 in ovarian cancer |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972042/ https://www.ncbi.nlm.nih.gov/pubmed/36259156 http://dx.doi.org/10.1002/cam4.5246 |
work_keys_str_mv | AT wuqiulei identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT liguoqing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT gonglanqing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT caijing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT chenle identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT xuxiaohan identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT liuxiaoli identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT zhaojing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT zengya identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT gaorui identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT yulili identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer AT wangzehua identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer |